203 related articles for article (PubMed ID: 26158900)
21. miR-652 Promotes Proliferation and Migration of Uveal Melanoma Cells by Targeting HOXA9.
Xia Z; Yang C; Yang X; Wu S; Feng Z; Qu L; Chen X; Liu L; Ma Y
Med Sci Monit; 2019 Nov; 25():8722-8732. PubMed ID: 31740654
[TBL] [Abstract][Full Text] [Related]
22. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; van Ijcken WF; Wozniak A; Sciot R; Rutkowski P; Schöffski P; Taguchi T; Mathijssen RH; Verweij J; Sleijfer S; Debiec-Rychter M; Wiemer EA
Br J Cancer; 2013 Sep; 109(6):1625-35. PubMed ID: 23969726
[TBL] [Abstract][Full Text] [Related]
23. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
24. miR-25 Promotes Melanoma Progression by regulating RNA binding motif protein 47.
Jiang QQ; Liu WB
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():59-65. PubMed ID: 30403177
[TBL] [Abstract][Full Text] [Related]
25. miR-137 inhibits proliferation of melanoma cells by targeting PAK2.
Hao S; Luo C; Abukiwan A; Wang G; He J; Huang L; Weber CE; Lv N; Xiao X; Eichmüller SB; He D
Exp Dermatol; 2015 Dec; 24(12):947-52. PubMed ID: 26186482
[TBL] [Abstract][Full Text] [Related]
26. MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b.
Zhang J; Lu L; Xiong Y; Qin W; Zhang Y; Qian Y; Jiang H; Liu W
Clin Exp Dermatol; 2014 Apr; 39(3):376-84. PubMed ID: 24635082
[TBL] [Abstract][Full Text] [Related]
27. miR-194 is a negative regulator of GEF-H1 pathway in melanoma.
Guo B; Hui Q; Zhang Y; Chang P; Tao K
Oncol Rep; 2016 Oct; 36(4):2412-20. PubMed ID: 27573550
[TBL] [Abstract][Full Text] [Related]
28. Stathmin 1 is a potential novel oncogene in melanoma.
Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of miR-1280 in melanoma by regulation of Src.
Sun V; Zhou WB; Nosrati M; Majid S; Thummala S; de Semir D; Bezrookove V; de Feraudy S; Chun L; Schadendorf D; Debs R; Kashani-Sabet M; Dar AA
Mol Ther; 2015 Jan; 23(1):71-8. PubMed ID: 25195599
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
31. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis.
Zhao G; Li Q; Wang A; Jiao J
J Exp Clin Cancer Res; 2015 Jun; 34(1):66. PubMed ID: 26104682
[TBL] [Abstract][Full Text] [Related]
32. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
[TBL] [Abstract][Full Text] [Related]
33. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
[TBL] [Abstract][Full Text] [Related]
34. MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression.
Qiu HJ; Lu XH; Yang SS; Weng CY; Zhang EK; Chen FC
Biomed Pharmacother; 2016 Aug; 82():117-23. PubMed ID: 27470346
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
36. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
37. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
D'Aguanno S; Valentini E; Tupone MG; Desideri M; Di Martile M; Spagnuolo M; Buglioni S; Ercolani C; Falcone I; De Dominici M; Milella M; Rizzo MG; Calabretta B; Cota C; Anichini A; Trisciuoglio D; Del Bufalo D
J Exp Clin Cancer Res; 2018 Nov; 37(1):278. PubMed ID: 30454024
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.
Sakurai E; Maesawa C; Shibazaki M; Yasuhira S; Oikawa H; Sato M; Tsunoda K; Ishikawa Y; Watanabe A; Takahashi K; Akasaka T; Masuda T
Int J Oncol; 2011 Sep; 39(3):665-72. PubMed ID: 21687938
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
